The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Intervention for Monitoring of Salt Intake in Hypertensive Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05397054
Recruitment Status : Recruiting
First Posted : May 31, 2022
Last Update Posted : June 8, 2022
Sponsor:
Collaborators:
World Health Organization
Thai health promotion foundation.
Information provided by (Responsible Party):
Mahidol University

Tracking Information
First Submitted Date  ICMJE May 25, 2022
First Posted Date  ICMJE May 31, 2022
Last Update Posted Date June 8, 2022
Actual Study Start Date  ICMJE January 10, 2022
Estimated Primary Completion Date May 30, 2022   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: May 25, 2022)
24-hour urine sodium excretion [ Time Frame: 12 weeks ]
Compare the change of 24-hour urine sodium excretion between intervention group, received education, reformulation, environmental change and monitoring of salt intake by salt meter and control group, received standard treatment
Original Primary Outcome Measures  ICMJE Same as current
Change History
Current Secondary Outcome Measures  ICMJE
 (submitted: May 25, 2022)
blood pressure [ Time Frame: 4, 8 12 weeks ]
Compare the change systolic and diastolic blood pressure between intervention group, received education, reformulation, environmental change and monitoring of salt intake by salt meter and control group, received standard treatment
Original Secondary Outcome Measures  ICMJE Same as current
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE Intervention for Monitoring of Salt Intake in Hypertensive Patients
Official Title  ICMJE Community-based Intervention for Monitoring of Salt Intake in Hypertensive Patients
Brief Summary Sodium is an essential nutrient for humans, but excessive sodium consumption is causally associated with high blood pressure and increase risk of cardiovascular diseases. Dietary sodium consumption of greater than the recommended daily amount of 5 grams of salt or 2,000 mg of sodium is a major risk factor for CVD-related mortality. From recent national survey, Thai people had consumed more than 9.1 g of salt per day, which was nearly two times above WHO reference level. Dietary salt reduction was unsuccessful because of lacking awareness, and the higher threshold to detect salt taste in chronic high salt ingestion. To create awareness in the community, we should be educated, managed the environmental for salt reduction, and used salt meter to detect sodium content in daily food. This study aimed to compare the efficacy of intervention; education, reformulation, environmental change and used salt meter compared with standard treatment alone in terms of salt intake reduction and blood pressure.
Detailed Description A randomized-controlled trial was conducted in adult 18-70 years old with hypertensive patients (SBP>130 mmHg) in Uthaithani. Participants were randomized to intervention groups (education, reformulation, environmental change and used salt meter) and control group (standard education and treatment). Trial was followed up for 12 weeks. The primary objective was change in 24-hour urinary sodium excretion between groups and secondary objectives was change in systolic and diastolic blood pressure.
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Condition  ICMJE
  • Hypertension
  • Salt; Excess
Intervention  ICMJE
  • Behavioral: Education
    - Education: Education about risk of high sodium intake, type of sodium, nutrition ingredients
  • Behavioral: Reformulation
    - Reformulation: Dietary recommendation in low sodium intake
  • Behavioral: Environmental change
    - Environmental change: Encourage about low sodium intake in community
  • Device: Salt meter
    - Used salt meter: at least 3 times/wk
  • Behavioral: standard treatment
    standard treatment
Study Arms  ICMJE
  • Experimental: Investigator
    Education, Reformulation, Environmental change, Used salt meter
    Interventions:
    • Behavioral: Education
    • Behavioral: Reformulation
    • Behavioral: Environmental change
    • Device: Salt meter
  • Active Comparator: Control
    standard treatment with standard education
    Intervention: Behavioral: standard treatment
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Recruiting
Estimated Enrollment  ICMJE
 (submitted: May 25, 2022)
240
Original Estimated Enrollment  ICMJE Same as current
Estimated Study Completion Date  ICMJE June 30, 2022
Estimated Primary Completion Date May 30, 2022   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • Adults 18-70 years of age with hypertension
  • Systolic blood pressure > 130 mmHg
  • Provided informed consent to participate in the study

Exclusion Criteria:

  • Participants with end stage kidney disease
  • History of adjust antihypertensive agents or diuretic within 2 weeks before enrollment
  • Pregnant or breastfeeding women
  • Adjustment of any antihypertensive agents during study period
  • Participants with salt supplement
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Gender Based Eligibility: Yes
Ages  ICMJE 18 Years to 70 Years   (Adult, Older Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE
Contact: PITCHAPORN SONUCH 022011000 pitch_bell@hotmail.com
Listed Location Countries  ICMJE Thailand
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT05397054
Other Study ID Numbers  ICMJE COA. MURA2021/1004
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement  ICMJE Not Provided
Current Responsible Party Mahidol University
Original Responsible Party Same as current
Current Study Sponsor  ICMJE Mahidol University
Original Study Sponsor  ICMJE Same as current
Collaborators  ICMJE
  • World Health Organization
  • Thai health promotion foundation.
Investigators  ICMJE Not Provided
PRS Account Mahidol University
Verification Date June 2022

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP